The latest LifeSci SPAC said it is targeting companies in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors. Read more.
LifeSci II Amends Prospectus on $75M IPO
Related Posts
Marquee Raine Completes $374M IPO
The SPAC is focused on interactive technology companies.
IX Acquisition Files for $200M IPO
The new SPAC plans to focus on companies in the TMT and ICT industries.
Proxy on $810M Quantum-Si & HighCape Capital Merger Declared Effective
The transaction is expected to deliver up to $540 million of gross proceeds, including up to $115 million of cash held in HighCape’s trust account.
Bright Lights Amends $200M IPO Prospectus
The intended raise remains unchanged from the SPAC's initial registration last month.